CNS Pharmaceuticals (CNSP) Insider Trading & Ownership $0.12 -0.01 (-7.44%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends CNS Pharmaceuticals (NASDAQ:CNSP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.07%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$73,751.00Number OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$46,350.00 Get CNSP Insider Trade Alerts Want to know when executives and insiders are buying or selling CNS Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CNSP Insider Buying and Selling by Quarter Ad Genesis Gold GroupBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.Get your FREE, no-obligation Wealth Protection Guide now CNS Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/22/2023Christopher DownsCFOBuy540$63.50$34,290.00 8/16/2023John M ClimacoCEOBuy55$90.00$4,950.00 4/19/2023Jerzy GumulkaDirectorBuy50$85.00$4,250.00 4/17/2023Christopher DownsCFOBuy62$160.00$9,920.00 4/12/2023John M ClimacoCEOBuy300$34.50$10,350.00 4/10/2023Jerzy GumulkaDirectorBuy143$37.00$5,291.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 3/27/2023Waldemar PriebeMajor ShareholderSell100$54.50$5,450.00 3/24/2023Waldemar PriebeMajor ShareholderSell100$54.00$5,400.00 3/22/2023Waldemar PriebeMajor ShareholderSell100$54.00$5,400.00 3/20/2023Waldemar PriebeMajor ShareholderSell100$54.00$5,400.00 3/17/2023Waldemar PriebeMajor ShareholderSell100$56.50$5,650.00 3/15/2023Waldemar PriebeMajor ShareholderSell100$61.00$6,100.00 3/13/2023Waldemar PriebeMajor ShareholderSell100$65.00$6,500.00 3/10/2023Waldemar PriebeMajor ShareholderSell100$64.50$6,450.00 12/6/2021Christopher DownsCFOBuy100$47.00$4,700.00 (Data available from 1/1/2013 forward) CNSP Insider Trading Activity - Frequently Asked Questions Who is on CNS Pharmaceuticals's Insider Roster? The list of insiders at CNS Pharmaceuticals includes Christopher Downs, Jerzy Gumulka, John M Climaco, and Waldemar Priebe. Learn more on insiders at CNSP. What percentage of CNS Pharmaceuticals stock is owned by insiders? 0.07% of CNS Pharmaceuticals stock is owned by insiders. Learn more on CNSP's insider holdings. Which CNS Pharmaceuticals insiders have been buying company stock? The following insiders have purchased CNSP shares in the last 24 months: Christopher Downs ($44,210.00), Jerzy Gumulka ($9,541.00), and John M Climaco ($15,300.00). How much insider buying is happening at CNS Pharmaceuticals? Insiders have purchased a total of 1,150 CNSP shares in the last 24 months for a total of $69,051.00 bought. Which CNS Pharmaceuticals insiders have been selling company stock? The following insider sold CNSP shares in the last 24 months: Waldemar Priebe ($46,350.00). How much insider selling is happening at CNS Pharmaceuticals? Insiders have sold a total of 800 CNS Pharmaceuticals shares in the last 24 months for a total of $46,350.00 sold. CNS Pharmaceuticals Key ExecutivesMr. John Michael Climaco Esq. (Age 55)J.D., CEO, President & Director Compensation: $525kMr. Christopher S. Downs CPA (Age 45)CTP, FP&A, Chief Financial Officer Compensation: $382.16kDr. Sandra L. Silberman M.D. (Age 68)Ph.D., Chief Medical Officer Compensation: $261.2kDr. Waldemar Priebe Ph.D.FounderDr. Donald H. Picker Ph.D. (Age 78)Chief Science Officer More Insider Trading Tools from MarketBeat Related Companies CPIX Insider Trading CARA Insider Trading SYBX Insider Trading MTEX Insider Trading APRE Insider Trading NERV Insider Trading TXMD Insider Trading BGXX Insider Trading INAB Insider Trading NRXP Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:CNSP) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CNS Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CNS Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CNSP Stock Alerts